Proof of Usefulness Report

Vysioneer

Analysis completed on 1/24/2026

+618
Proof of Usefulness Score
Category Standard

The project represents a high-utility, FDA-cleared oncology AI platform with verified partnerships (Pfizer, Stanford, NTUH). While the submission itself was of extremely poor quality (containing false claims of 'everyone' reach and confusing financial data), independent verification confirms the existence of the 'VBrain' technology and significant B2B traction. The score reflects the high real-world value of cancer treatment AI, penalized by the lack of effort and accuracy in the submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+285
Audience Reach Impact+40
Technical Innovation+162
Evidence Of Traction+175
Market Timing Relevance+90
Functional Completeness+2.5
Subtotal+754.5
Usefulness Multiplierx0.82
Final Score+618

Project Details

Project URL
vysioneer.com
Description
Vysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we help pharma companies unlock lesion-level tumor characteristics to de-risk and accelerate clinical trials. Vysioneer is using the AI platform to build the world’s largest database of lesion-level drug efficacy.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline